FOREX.com by StoneX logo

JD Remains supported by a bullish trend line

JD fell more than 7% after the 3Q result, where are the support and resistance levels?

Global Author
Global Author

Share this:

JD.com (JD) Remains supported by a bullish trend line

JD.com (JD), a Chinese e-commerce company, announced that 3Q adjusted net income jumped 80.1% on year to 5.6 billion yuan ($0.8 billion) on net revenue of 174.2 billion yuan ($25.7 billion), up 29.2%. Annual active customer accounts rose 32.1% to 442 million in the twelve months ended September 30. Although the 3Q result beat the estimation, the stock prices fell 7.4% to the close price at $85.26.


Besides, the stock of JD.com trading in Hong Kong Exchange will join the Hang Seng China Enterprises Index from December 7. CICC projected that there would be $66M passive capital inflow. On the other hand, the company will spin-off its JD Health to list in Hong Kong Exchange for raising $3 billion.

From a technical point of view, although the ADR stock prices of JD.com posted a pullback from $92.65, it is still supported by a rising trend line drawn from February. In addition, the ascending 20-day and 50-day moving averages are playing the support role. The relative strength index still holds above the support level at 46.

Bullish readers could set the support level at $78.00, while resistance levels would be located at $92.65 and $98.40.


Source: GAIN Capital, TradingView

JD.com (JD), a Chinese e-commerce company, announced that 3Q adjusted net income jumped 80.1% on year to 5.6 billion yuan ($0.8 billion) on net revenue of 174.2 billion yuan ($25.7 billion), up 29.2%. Annual active customer accounts rose 32.1% to 442 million in the twelve months ended September 30. Although the 3Q result beat the estimation, the stock prices fell 7.4% to the close price at $85.26.


Besides, the stock of JD.com trading in Hong Kong Exchange will join the Hang Seng China Enterprises Index from December 7. CICC projected that there would be $66M passive capital inflow. On the other hand, the company will spin-off its JD Health to list in Hong Kong Exchange for raising $3 billion.

From a technical point of view, although the ADR stock prices of JD.com posted a pullback from $92.65, it is still supported by a rising trend line drawn from February. In addition, the ascending 20-day and 50-day moving averages are playing the support role. The relative strength index still holds above the support level at 46.

Bullish readers could set the support level at $78.00, while resistance levels would be located at $92.65 and $98.40.


Source: GAIN Capital, TradingView

The complete CFD trading experience

Award-winning platforms, competitive spreads, low commissions and dedicated support.

We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.

Economic calendar

Web Trader platform

Our sophisticated web-based platform is packed with features.

Related articles

StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.

StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.

It's your world. Trade it.